Europe Health Technology Assessment Associate Lead

Role Overview

This opportunity involves deep collaboration with regional access leads to identify and address the evidence requirements of Health Technology Assessment (HTA) stakeholders across Europe. Engage with internal cross-functional teams to compile and analyze relevant data for HTA-related projects such as PICO surveys and data consolidation.

Key Responsibilities

• Co-lead the formation of market access strategies and clinical development plans specifically for Takeda’s oncology portfolio, concentrating on the evidence needs of HTA and payer entities in Europe and Canada.
• Participate in the preparation and submission of Health Technology Assessment documentation for the European Union, including Joint Clinical Assessments and Joint Scientific Consultations, ensuring adherence to EU Joint HTA guidelines.
• Enhance awareness and promote Takeda’s values by fostering collaboration among cross-functional and global teams as well as regional partners to meet EU HTA evidence requirements.
• Ensure thorough mapping of HTA and payer evidence requirements through PICO simulations for assigned assets, contributing to global development and evidence generation plans.
• Represent the joint EU HTA archetype’s evidence needs within regional and global forums, effectively communicating updates and strategic insights regarding HTA guidance and methodologies.
• Co-lead initiatives for Joint Scientific Consultations to gather clinical trial feedback that informs development and evidence generation strategies.
• Serve as the primary contact for all evidence-related topics concerning Joint Clinical Assessments and Joint Scientific Consultations for designated priority assets.
• Advise internal stakeholders on the methodological specifics related to the EU HTA Regulation, complementing existing expertise in product areas.
• Maintain current knowledge of EU HTA guidelines and processes while disseminating relevant updates to internal stakeholders.
• Analyze dynamic relationships and collaborations among national HTA/payer bodies, generating strategic insights for global PVA initiatives and shaping reimbursement strategies.

Qualifications and Skills

Required Qualifications

• A minimum of a bachelor's degree, with an advanced degree preferred (MSc, PhD, MPH, MPP, MBA).
• At least 6 years of experience within the biopharmaceutical industry or healthcare consulting.
• A minimum of 4 years focused on market access, health economics, pricing, and health policy, demonstrating increasing responsibility in similar roles.
• Strong comprehension of the EU payer and HTA landscape, including reimbursement structures and methodologies.
• Exceptional verbal and written communication abilities with proven capacity to influence stakeholders.
• Experience in managing complex projects and effectively engaging multiple stakeholders under pressure.
• Familiarity with drug development processes and collaboration within global pharmaceutical teams.
• Proficient in navigating ambiguity and managing trade-offs in discussions, driving HTA submissions towards optimal outcomes.
• Adept at translating evidence into value propositions for advocacy and stakeholder engagement.

Preferred Qualifications

• Advanced degree in a relevant field.
• Certification in health economics or economic evaluations.
• Previous experience within oncology.
• Involvement in regional or global roles.
• Direct experience leading national HTA submissions or early scientific advice with HTA or regulatory agencies is advantageous.

Additional Information

• Willingness to travel domestically and internationally up to 20% of the time.
• Experience in addressing evidence needs for major HTA and payer stakeholders in EU5 and/or Canada.
• Excellent collaboration and communication skills in navigating matrix environments.
• A solution-oriented mindset with experience in internal stakeholder management.
• A robust understanding of the clinical development process.